Chen-Xu M et al
Therefore, it demonstrates significant efficacy in weight loss , blood sugar control , and cardiovascular protection , making it an important treatment option for type 2 diabetes patients and individuals managing their weight
Ozempic is a GLP-1 receptor agonist that mimics the hormone glucagon-like peptide-1, slowing gastric emptying, reducing appetite, and improving insulin sensitivity
The verified identifiers are CAS 1415456-99-3, molecular formula C194H312N54O59S2, molecular weight 4409 g/mol and PubChem CID 171397054
By reducing caloric intake, MT2 can complement diet and exercise regimens, aiding in achieving weight loss goals
Retatrutide is an investigational once-weekly injectable peptide that simultaneously activates GLP-1, GIP, and glucagon receptors, distinguishing it from approved single or dual receptor agonists such as semaglutide and tirzepatide